A Pilot Study of Reduced Dose Radiotherapy Delivered In Standard Fractionation to Improve The Therapeutic Index For Stereotactic Treatment Of Juxtapapillary Choroidal Melanoma.
Participants with uveal melanoma at the macula (centre of the retina) are treated with low dose fractionated radiation (60 Gy in 30 fractions and 5 fractions per week) and monitored for 10 years.
Trial Registry Number: ACTRN12614000531617
